Elizabeth G. O’Farrell's most recent trade in LENSAR Inc was a trade of 7,374 Common Stock done . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LENSAR Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 7,374 | 49,947 | - | 0 | Common Stock | |
| Geron Corp. | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 180,000 | 180,000 | - | - | Stock Option (right to buy) | |
| LENSAR Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 22,000 | 42,573 | - | 0 | Common Stock | |
| Geron Corp. | Elizabeth G. O’Farrell | Director | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 24 Aug 2023 | 6,607 | 7,407 (0%) | 0% | 2.3 | 15,064 | Common Stock |
| Geron Corp. | Elizabeth G. O’Farrell | Director | Purchase of securities on an exchange or from another person at price $ 2.28 per share. | 24 Aug 2023 | 6,579 | 26,220 (0%) | 0% | 2.3 | 15,000 | Common Stock |
| Geron Corp. | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| LENSAR Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 33,175 | 33,175 | - | - | Stock Option (Right to Buy) | |
| LENSAR Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 9,288 | 20,573 | - | 0 | Common Stock | |
| Inhibikase Therapeutics Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Inhibikase Therapeutics Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 22,677 | 22,677 | - | - | Stock Option (right to buy) | |
| LENSAR Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 20,847 | 20,847 | - | - | Stock Option (Right to Buy) | |
| Geron Corp. | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | |
| LENSAR Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 13,445 | 13,445 | - | - | Stock Option (Right to Buy) | |
| LENSAR Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 28,249 | 28,249 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 6,825 | 6,825 | - | - | Stock Option (right to buy) | |
| Geron Corp. | Elizabeth G. O’Farrell | Director | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 21 Aug 2020 | 17,441 | 19,641 (0%) | 0% | 1.7 | 30,173 | Common Stock |